109 related articles for article (PubMed ID: 32768248)
1. Epstein-Barr virus is a promoter of lymphoma cell metastasis.
Shimada S; Kawasaki H; Diao Y; Ren HY; Li WH; Tang MQ
Pathology; 2020 Oct; 52(6):676-685. PubMed ID: 32768248
[TBL] [Abstract][Full Text] [Related]
2. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
3. Proteomic and phospholipidomic characterization of extracellular vesicles inducing tumor microenvironment in Epstein-Barr virus-associated lymphomas.
Ito M; Kudo K; Higuchi H; Otsuka H; Tanaka M; Fukunishi N; Araki T; Takamatsu M; Ino Y; Kimura Y; Kotani A
FASEB J; 2021 Apr; 35(4):e21505. PubMed ID: 33723887
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus and the pathogenesis of lymphoma.
Vockerodt M; Yap LF; Shannon-Lowe C; Curley H; Wei W; Vrzalikova K; Murray PG
J Pathol; 2015 Jan; 235(2):312-22. PubMed ID: 25294567
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas.
Dolcetti R
Semin Cancer Biol; 2015 Oct; 34():58-69. PubMed ID: 25953434
[TBL] [Abstract][Full Text] [Related]
6. Role of exosomes as a proinflammatory mediator in the development of EBV-associated lymphoma.
Higuchi H; Yamakawa N; Imadome KI; Yahata T; Kotaki R; Ogata J; Kakizaki M; Fujita K; Lu J; Yokoyama K; Okuyama K; Sato A; Takamatsu M; Kurosaki N; Alba SM; Azhim A; Horie R; Watanabe T; Kitamura T; Ando K; Kashiwagi T; Matsui T; Okamoto A; Handa H; Kuroda M; Nakamura N; Kotani A
Blood; 2018 Jun; 131(23):2552-2567. PubMed ID: 29685921
[TBL] [Abstract][Full Text] [Related]
7. Lactic Acid Downregulates Viral MicroRNA To Promote Epstein-Barr Virus-Immortalized B Lymphoblastic Cell Adhesion and Growth.
Mo X; Wei F; Tong Y; Ding L; Zhu Q; Du S; Tan F; Zhu C; Wang Y; Yu Q; Liu Y; Robertson ES; Yuan Z; Cai Q
J Virol; 2018 May; 92(9):. PubMed ID: 29444941
[TBL] [Abstract][Full Text] [Related]
8. [Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].
Chen X; Li D; Huang Z; Zhong S; Cai L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1776-1783. PubMed ID: 33380393
[TBL] [Abstract][Full Text] [Related]
9. Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression.
Trivedi P; Takazawa K; Zompetta C; Cuomo L; Anastasiadou E; Carbone A; Uccini S; Belardelli F; Takada K; Frati L; Faggioni A
Blood; 2004 Jan; 103(1):313-6. PubMed ID: 12969959
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus: 40 years on.
Young LS; Rickinson AB
Nat Rev Cancer; 2004 Oct; 4(10):757-68. PubMed ID: 15510157
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
Auerbach A; Aguilera NS
Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus: more than 50 years old and still providing surprises.
Young LS; Yap LF; Murray PG
Nat Rev Cancer; 2016 Dec; 16(12):789-802. PubMed ID: 27687982
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection.
Takakuwa T; Luo WJ; Ham MF; Mizuki M; Iuchi K; Aozasa K
Cancer Sci; 2003 Oct; 94(10):858-63. PubMed ID: 14556658
[TBL] [Abstract][Full Text] [Related]
16. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Epstein-Barr virus load in pyothorax-associated lymphoma.
Shide K; Henzan H; Nagafuji K; Aoki K; Miyamoto T; Shimoda K; Kazuyama Y; Ohshima K; Gondo H; Harada M
J Med Virol; 2003 May; 70(1):137-40. PubMed ID: 12629655
[TBL] [Abstract][Full Text] [Related]
18. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
20. Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma.
Cen O; Kannan K; Huck Sappal J; Yu J; Zhang M; Arikan M; Ucur A; Ustek D; Cen Y; Gordon L; Longnecker R
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
